{"content":"<li class=\"n-box-item date-title\" data-end=\"1470455999\" data-start=\"1470369600\" data-txt=\"Sunday, December 22, 2019\">Friday, August  5, 2016</li><li class=\"n-box-item sa-box-item\" data-id=\"3200864\" data-ts=\"1470438431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LUV\" target=\"_blank\">LUV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200864-southwest-airlines-to-unions-ceo-is-staying-in-post\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Southwest Airlines to unions: CEO is staying in post</a></h4><ul>   <li>The board at Southwest Airlines (<a href=\"https://seekingalpha.com/symbol/LUV\" title=\"Southwest Airlines Co.\">LUV</a> <font color=\"green\">+3.9%</font>) says its CEO <a href=\"http://abcnews.go.com/Business/wireStory/southwest-airlines-board-tells-unions-ceo-staying-41154290\" target=\"_blank\">Gary Kelly is staying put</a>, amid demands by unions for him to step down.</li>    <li>Unions (including a <a href=\"https://seekingalpha.com/news/3198261-pilots-make-noise-southwest-airlines\" target=\"_blank\">pilots union</a> as well as unions repping <a href=\"https://seekingalpha.com/news/3199317-labor-unrest-southwest-airlines-amid-record-profit\" target=\"_blank\">baggage handlers and ground workers</a>) have been asking CEO Gary Kelly and COO Mike Van de Ven to exit their posts.</li>    <li>In a letter, the company's board cited a long list of Kelly's achievements and says calling for his removal was without merit and reckless.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200864\" data-linked=\"Southwest Airlines to unions: CEO is staying in post\" data-tweet=\"$LUV - Southwest Airlines to unions: CEO is staying in post https://seekingalpha.com/news/3200864-southwest-airlines-to-unions-ceo-is-staying-in-post?source=tweet\" data-url=\"https://seekingalpha.com/news/3200864-southwest-airlines-to-unions-ceo-is-staying-in-post\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200861\" data-ts=\"1470437522\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SHEN\" target=\"_blank\">SHEN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200861-shentel-tumbles-14_7-swings-to-post-merger-loss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shentel tumbles 14.7% as it swings to post-merger loss</a></h4><ul>   <li>After it hit a 52-week high just a few weeks ago, Shenandoah Telecommunications (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SHEN\" title=\"Shenandoah Telecommunications Co\">SHEN</a>) <font color=\"red\">slid 14.7%</font> today as it swung to a surprising <a href=\"https://seekingalpha.com/news/3200635-shenandoah-eps-0_14\" target=\"_blank\">loss in Q2 earnings</a>.</li>    <li>Revenue gains of 52% came almost entirely due to its <a href=\"https://seekingalpha.com/news/3173488-shentel-gets-fcc-ok-640m-ntelos-buyout\" target=\"_blank\">acquisition of NTELOS Holdings</a>, wrapped on May 6.</li>    <li>OIBDA was up 48.5% to $55.9M but missed an expected $66M.</li>    <li>The company acquired some 404,000 postpaid customers and 155,000 prepaid customers from NTELOS and Sprint.</li>    <li>Revenue by segment: Wireless, $94.3M (up 78.2%); Cable, $26.4M (up 9.3%); Wireline, $18.6M (up 12.9%).</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3200861\" data-linked=\"Shentel tumbles 14.7% as it swings to post-merger loss\" data-tweet=\"$SHEN - Shentel tumbles 14.7% as it swings to post-merger loss https://seekingalpha.com/news/3200861-shentel-tumbles-14_7-swings-to-post-merger-loss?source=tweet\" data-url=\"https://seekingalpha.com/news/3200861-shentel-tumbles-14_7-swings-to-post-merger-loss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200858\" data-ts=\"1470434869\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DVAX\" target=\"_blank\">DVAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200858-dynavaxs-hepatitis-b-candidate-gets-ad-comm-review-nov-16\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Dynavax&#39;s hepatitis B candidate gets Ad Comm review Nov. 16</a></h4><ul>   <li>Dynavax (<a href=\"https://seekingalpha.com/symbol/DVAX\" title=\"Dynavax Technologies Corporation\">DVAX</a> <font color=\"green\">+4.9%</font>) says its biologics license application for hepatitis B vaccine Heplisav-B is headed for an Advisory Committee meeting on Nov. 16.</li>    <li>The vaccine candidate is under review with a Prescription Drug User Fee Act action date of Dec. 15.</li>    <li>The FDA will communicate questions for its Vaccines and Related Biological Products Ad Comm to review closer to the meeting date.</li>    <li>Heplisav-B combines hepatitis B surface antigen with a proprietary Toll-like Receptor 9 agonist to enhance the immune response, Dynavax says. It's administered in two doses over one month.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200858\" data-linked=\"Dynavax&#39;s hepatitis B candidate gets Ad Comm review Nov. 16\" data-tweet=\"$DVAX - Dynavax&#39;s hepatitis B candidate gets Ad Comm review Nov. 16 https://seekingalpha.com/news/3200858-dynavaxs-hepatitis-b-candidate-gets-ad-comm-review-nov-16?source=tweet\" data-url=\"https://seekingalpha.com/news/3200858-dynavaxs-hepatitis-b-candidate-gets-ad-comm-review-nov-16\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>45&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200845\" data-ts=\"1470433338\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200845-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li>\n<b>Top gainers, as of 5.25 p.m.:</b> <a href=\"https://seekingalpha.com/symbol/ERI\" title=\"Eldorado Resorts, Inc.\">ERI</a> <font color=\"green\">+3.6%</font>. <a href=\"https://seekingalpha.com/symbol/OCUL\" title=\"Ocular Therapeutix\">OCUL</a> <font color=\"green\">+3.4%</font>. <a href=\"https://seekingalpha.com/symbol/SWIR\" title=\"Sierra Wireless, Inc.\">SWIR</a> <font color=\"green\">+2.5%</font>. <a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"green\">+2.5%</font>. LGF <font color=\"green\">+2.2%</font>.</li>\n<li>\n<b>Top losers, as of 5.25p.m.:</b> <a href=\"https://seekingalpha.com/symbol/CEMP\" title=\"Cempra, Inc.\">CEMP</a> <font color=\"red\">-3.7%</font>. <a href=\"https://seekingalpha.com/symbol/ETFC\" title=\"E*TRADE Financial Corporation\">ETFC</a> <font color=\"red\">-3.0%</font>. <a href=\"https://seekingalpha.com/symbol/LNTH\" title=\"Lantheus Holdings\">LNTH</a> <font color=\"red\">-2.8%</font>. <a href=\"https://seekingalpha.com/symbol/ABB\" title=\"ABB LTD.\">ABB</a> <font color=\"red\">-2.6%</font>. <a href=\"https://seekingalpha.com/symbol/UL\" title=\"Unilever Plc\">UL</a> <font color=\"red\">-2.3%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200845\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$ERI $OCUL $SWIR - After Hours Gainers / Losers https://seekingalpha.com/news/3200845-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3200845-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200842\" data-ts=\"1470431896\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TDS\" target=\"_blank\">TDS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200842-telephone-data-systems-up-after-q2-beats-customer-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telephone &amp; Data Systems up after Q2 beats, customer gains</a></h4><ul>   <li>Telephone &amp; Data Systems (<a href=\"https://seekingalpha.com/symbol/TDS\" title=\"Telephone and Data Systems, Inc.\">TDS</a> <font color=\"green\">+1.4%</font>) gained again alongside <a href=\"https://seekingalpha.com/news/3200837-u-s-cellular-rises-2-percent-q2-beat-customer-gains\" target=\"_blank\">strong results</a> from U.S. Cellular (<a href=\"https://seekingalpha.com/symbol/USM\" title=\"United States Cellular Corporation\">USM</a> <font color=\"green\">+2.1%</font>), <a href=\"https://seekingalpha.com/news/3200656-telephone-data-systems-beats-0_12-beats-revenue\" target=\"_blank\">beating on top and bottom lines</a> in Q2 despite flat revenues.</li>    <li>Revenues rose fractionally at U.S. Cellular, of which TDS holds a heavy majority. It was the same in TDS consolidated results, where revenues rose just $7M to $1.283B. Net income rose to $28M from a year-ago $23M.</li>    <li>Customers had gained at U.S. Cellular; separate from that, TDS Telecom saw wireline connections rise 0.4% Y/Y to 590,200, up from the previous quarter's 585,800. Voice connections fell to 316,800 from last year's 329,000; broadband connections gained to 232,200 from 231,200; IPTV rose to 41,200 from 27,900.</li>    <li>Residential revenue per connection of $43.67 was up vs. a year-ago $42.10 and last quarter's $43.28.</li>    <li>TDS affirmed full-year guidance (U.S. Cellular had affirmed its own guidance as well): consolidated revenues of $5.04B-$5.29B, and EBITDA of $1B-$1.165B.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3200842\" data-linked=\"Telephone &amp; Data Systems up after Q2 beats, customer gains\" data-tweet=\"$TDS $TDS $USM - Telephone &amp; Data Systems up after Q2 beats, customer gains https://seekingalpha.com/news/3200842-telephone-data-systems-up-after-q2-beats-customer-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3200842-telephone-data-systems-up-after-q2-beats-customer-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:18 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200837\" data-ts=\"1470430865\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/USM\" target=\"_blank\">USM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200837-u-s-cellular-rises-2-q2-beat-customer-gains\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">U.S. Cellular rises 2% with Q2 beat, customer gains</a></h4><ul>   <li>U.S. Cellular (NYSE:<a href=\"https://seekingalpha.com/symbol/USM\" title=\"United States Cellular Corporation\">USM</a>) <font color=\"green\">gained 2.1%</font> today after it logged a <a href=\"https://seekingalpha.com/news/3200658-united-states-cellular-beats-0_09-beats-revenue\" target=\"_blank\">rebound quarter</a> with higher revenues and beats on top and bottom lines.</li>    <li>Revenue crept up fractionally to $980M, and net income rose 42%.</li>    <li>Net postpaid additions came to 36,000, bringing total postpaid customers to 4.49M. Net prepaid adds of 14,000 brought that customer base to 413,000.</li>    <li>Revenue breakout: Service, $762M (down 8%); Equipment sales, $218M (up 44%).</li>    <li>Postpaid ARPU was $47.37, down from a year-ago $53.62 and last quarter's $48.13. Prepaid ARPU fell to $34.58 from a year-ago $35.98 and last quarter's $35.51.</li>    <li>It affirmed full-year guidance: revenues of $3.9B-$4.1B and EBITDA of $725M-$850M.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3200837\" data-linked=\"U.S. Cellular rises 2% with Q2 beat, customer gains\" data-tweet=\"$USM - U.S. Cellular rises 2% with Q2 beat, customer gains https://seekingalpha.com/news/3200837-u-s-cellular-rises-2-q2-beat-customer-gains?source=tweet\" data-url=\"https://seekingalpha.com/news/3200837-u-s-cellular-rises-2-q2-beat-customer-gains\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200830\" data-ts=\"1470429413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ISNS\" target=\"_blank\">ISNS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200830-image-sensing-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Image Sensing reports Q2 results</a></h4><ul>\n<li>Image Sensing (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ISNS\" title=\"Image Sensing Systems, Inc.\">ISNS</a>): Q2 EPS of $0.24</li>\n<li>Revenue of $4.68M (+6.4% Y/Y)</li>\n<li>Shares <font color=\"green\">+54%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200830\" data-linked=\"Image Sensing reports Q2 results\" data-tweet=\"$ISNS - Image Sensing reports Q2 results https://seekingalpha.com/news/3200830-image-sensing-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3200830-image-sensing-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:36 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200810\" data-ts=\"1470427018\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200810-bloomberg-valeants-relistor-drug-draws-interest-from-potential-buyers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Valeant&#39;s Relistor drug draws interest from potential buyers</a></h4><ul>     <li>Valeant Pharmaceuticals' (VRX <font color=\"red\">-1%</font>) Relistor drug has <a href=\"http://www.bloomberg.com/news/articles/2016-08-05/valeant-s-relistor-said-to-draw-interest-from-potential-buyers\" target=\"_blank\">attracted  interest</a> from other companies that could value the constipation treatment at $400M-$500M, Bloomberg reports.</li>     <li>VRX and its partner for Relistor, Progenics Pharmaceuticals (<a href=\"https://seekingalpha.com/symbol/PGNX\" title=\"Progenics Pharmaceuticals Inc.\">PGNX</a> <font color=\"green\">+6.1%</font>), said last month that the FDA approved the tablet form of  the drug to treat constipation brought on by taking opioids for chronic, non-cancer pain.</li>\n<li>VRX has said it expects to start selling Relistor tablets in the U.S. in Q3; PGNX says it is entitled to receive as much as $200M of milestone payments tied to sales of the drug.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200810\" data-linked=\"Bloomberg: Valeant&#39;s Relistor drug draws interest from potential buyers\" data-tweet=\"$BHC $BHC $PGNX - Bloomberg: Valeant&#39;s Relistor drug draws interest from potential buyers https://seekingalpha.com/news/3200810-bloomberg-valeants-relistor-drug-draws-interest-from-potential-buyers?source=tweet\" data-url=\"https://seekingalpha.com/news/3200810-bloomberg-valeants-relistor-drug-draws-interest-from-potential-buyers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>79&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200802\" data-ts=\"1470425160\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMPV\" target=\"_blank\">IMPV</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200802-imperva-upgraded-needham-company-amid-strategic-alternatives-declaration\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Imperva upgraded at Needham &amp; Company amid strategic alternatives declaration</a></h4><ul>\n<li>Imperva (<a href=\"https://seekingalpha.com/symbol/IMPV\" title=\"Imperva, Inc.\">IMPV</a> <font color=\"green\">+1.2%</font>) <a href=\"https://seekingalpha.com/news/3200441-imperva-misses-0_06-misses-revenue\" target=\"_blank\">posted</a> lower-than-anticipated Q2 results yesterday, though announced it has retained <a href=\"http://www.qatalyst.com/\" target=\"_blank\">Qatalyst Partners</a> in an effort to explore options.</li>\n<li>Today, Needham &amp; Company analyst Scott Zeller <a href=\"http://www.streetinsider.com/Analyst+Comments/Needham+%26+Company+Upgrades+Imperva+%28IMPV%29+to+Buy+Amid+Potential+Sale%3B+%2464+PT/11907192.html\" target=\"_blank\">upgraded</a> Imperva to a Buy rating and issued a $64 price target (current price $45.59) based on 6x EV/CY17 revenue.</li>\n<li>Imperva projects Q3 revenue of $62M-$64M, gross margins of around 80%, operating loss of negative $5.4M to negative $4.2M and a net loss of negative $5.9M to negative $4.7M. Projects FY 2016 revenue of $$248.6M-$250.6M, gross margins of around 80%, operating loss of negative $24.5M to negative $23.3M, a net loss of negative $26.3M to negative $25.2M and capital expenditures of $18M-$20M. It additionally expects to generate positive cash flows from operations for the year.</li>\n<li>Needham &amp; Company feels the bar has been adequately lowered as a result of the weak quarter, issued guidance, bank hire and current share price.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200802\" data-linked=\"Imperva upgraded at Needham &amp; Company amid strategic alternatives declaration\" data-tweet=\"$IMPV - Imperva upgraded at Needham &amp; Company amid strategic alternatives declaration https://seekingalpha.com/news/3200802-imperva-upgraded-needham-company-amid-strategic-alternatives-declaration?source=tweet\" data-url=\"https://seekingalpha.com/news/3200802-imperva-upgraded-needham-company-amid-strategic-alternatives-declaration\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:26 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200805\" data-ts=\"1470425070\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FWONA\" target=\"_blank\">FWONA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200805-libertys-maffei-streaming-buy-be-linked-sirius-xm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty&#39;s Maffei: Any streaming buy would be linked with Sirius XM</a></h4><ul>   <li>On the company's <a href=\"https://seekingalpha.com/article/3996491-liberty-medias-lmca-ceo-greg-maffei-q2-2016-results-earnings-call-transcript?part=single\" target=\"_blank\">earnings call</a>, Liberty Media (LMCA) CEO Greg Maffei said that if the company went for streaming music, a purchase would be <a href=\"http://www.wsj.com/articles/liberty-media-chief-any-streaming-music-deal-would-be-housed-in-sirius-xm-1470422969\" target=\"_blank\">organized in the company's Sirius XM</a> (<a href=\"https://seekingalpha.com/symbol/SIRI\" title=\"Sirius XM Holdings Inc.\">SIRI</a> <font color=\"red\">-0.1%</font>) rather than at the parent level, where some other music businesses are housed.</li>    <li>Shares in Pandora (<a href=\"https://seekingalpha.com/symbol/P\" title=\"Pandora Media\">P</a> <font color=\"red\">-1.7%</font>) had risen two weeks ago on reports that Maffei had previously floated the idea of <a href=\"https://seekingalpha.com/news/3194850-wsj-liberty-floated-15-share-offer-pandora-combine-sirius-xm\" target=\"_blank\">buying the Internet radio company</a> for $15/share. Pandora shares are up more than 10% since that report, to $13.59 today.</li>    <li>\"I don't know how I could have been more negative on streaming services,\" Maffei said in the Q&amp;A. But: \"I think it's highly unlikely that anything would happen at the Liberty level. Sirius is our play for the online play for music, whether it's distributed through satellite or, as Sirius already does, through the online system.\"</li>    <li>Several big players are entering subscription streaming, \"likely to further commoditize the market,\" he notes. \"Spotify (MUSIC) did something, like, for the last year, $3.54 of ARPU per month and had 82% or 84% content costs. That sounds like a very hard business to me. And that is with Apple, Amazon, Google entering more deeply and more strongly.\"</li>    <li>Liberty Sirius XM Group (NASDAQ:<a href=\"https://seekingalpha.com/symbol/LSXMA\" title=\"Liberty Sirius XM Series A\">LSXMA</a>) is <font color=\"green\">up 0.2%</font> today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200805\" data-linked=\"Liberty&#39;s Maffei: Any streaming buy would be linked with Sirius XM\" data-tweet=\"$FWONA $FWONA $SPOT - Liberty&#39;s Maffei: Any streaming buy would be linked with Sirius XM https://seekingalpha.com/news/3200805-libertys-maffei-streaming-buy-be-linked-sirius-xm?source=tweet\" data-url=\"https://seekingalpha.com/news/3200805-libertys-maffei-streaming-buy-be-linked-sirius-xm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:24 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>142&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200804\" data-ts=\"1470424937\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ET\" target=\"_blank\">ET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200804-energy-transfer-partners-upgraded-to-buy-stifel\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy Transfer Partners upgraded to Buy at Stifel</a></h4><ul>     <li>Energy Transfer Partners (ETP <font color=\"green\">+1.4%</font>) is <a href=\"http://www.streetinsider.com/Upgrades/Stifel+Upgrades+Energy+Transfer+Partners+%28ETP%29+to+Buy/11907252.html\" target=\"_blank\">upgraded to Buy</a> from Hold with a $50 price target at Stifel, which cites an improved outlook and cheap valuation.</li>     <li>Stifel says ETP's reported distributable cash flow of $774M and Q2 coverage of 0.91x was in-line with its estimate (<a href=\"https://seekingalpha.com/news/3199692-energy-transfer-partners-and-nbsp-l-p-eps-line-misses-revenue\" target=\"_blank\">Q2 earnings</a>), and notes that Energy Transfer Equity (ETE <font color=\"green\">+3.3%</font>) plans to provide $645M of incremental waivers over the next six quarters, prompting the firm to bump its anticipated FY 2017 distribution coverage ratio to 1.07x from 0.97x.</li>     <li>Also, Stifel says ETP's sale <a href=\"https://seekingalpha.com/news/3199208-enbridge-marathon-petroleum-buy-2b-bakken-pipeline-stake\" target=\"_blank\">earlier this week</a> of part of its Bakken Pipeline project will free up the balance sheet and remove a significant portion of equity capital that was required.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200804\" data-linked=\"Energy Transfer Partners upgraded to Buy at Stifel\" data-tweet=\"$ET - Energy Transfer Partners upgraded to Buy at Stifel https://seekingalpha.com/news/3200804-energy-transfer-partners-upgraded-to-buy-stifel?source=tweet\" data-url=\"https://seekingalpha.com/news/3200804-energy-transfer-partners-upgraded-to-buy-stifel\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:22 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>103&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200796\" data-ts=\"1470423629\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200796-technology-top-5-gainers-losers-of-3-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top 5 Gainers / Losers as of 3:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/AMBR\" title=\"Amber Road, Inc.\">AMBR</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/CTRL\" title=\"Control4 Corporation\">CTRL</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/AAOI\" title=\"Applied Optoelectronics, Inc.\">AAOI</a> <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/PRCP\" title=\"Perceptron, Inc.\">PRCP</a> <font color=\"green\">+13%</font>. ABTL <font color=\"green\">+11%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CPSI\" title=\"Computer Programs and Systems, Inc.\">CPSI</a> <font color=\"red\">-30%</font>. <a href=\"https://seekingalpha.com/symbol/IMI\" title=\"Intermolecular, Inc.\">IMI</a> <font color=\"red\">-30%</font>. <a href=\"https://seekingalpha.com/symbol/HDP\" title=\"Hortonworks\">HDP</a> <font color=\"red\">-23%</font>. <a href=\"https://seekingalpha.com/symbol/XCOM\" title=\"Xtera Communications\">XCOM</a> <font color=\"red\">-21%</font>. <a href=\"https://seekingalpha.com/symbol/SWIR\" title=\"Sierra Wireless, Inc.\">SWIR</a> <font color=\"red\">-17%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200796\" data-linked=\"Technology - Top 5 Gainers / Losers as of 3:00 pm\" data-tweet=\"$AMBR $CTRL $AAOI - Technology - Top 5 Gainers / Losers as of 3:00 pm https://seekingalpha.com/news/3200796-technology-top-5-gainers-losers-of-3-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3200796-technology-top-5-gainers-losers-of-3-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200818\" data-ts=\"1470423587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRS\" target=\"_blank\">BRS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200818-bristow-warns-of-full-year-loss-cuts-capex-40-over-two-years\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristow warns of full-year loss, cuts capex by 40% over two years</a></h4><ul>     <li>Bristow Group (<a href=\"https://seekingalpha.com/symbol/BRS\" title=\"Bristow Group Inc.\">BRS</a> <font color=\"green\">+7.5%</font>) is higher despite reporting a larger than expected <a href=\"https://seekingalpha.com/news/3200442-bristow-misses-0_19-misses-revenue\" target=\"_blank\">Q2 loss</a> on a 21% Y/Y drop in revenues, and warning that it <a href=\"http://www.nasdaq.com/article/bristow-forecasts-fullyear-lossupdate-20160805-00582\" target=\"_blank\">will slide to a full-year loss</a> as it copes with the energy industry downturn and currency headwinds created by the Brexit vote.</li>     <li>BRS says it will cut planned capital spending by 40% over the next two years as oil and gas companies cut back on exploration and production.</li>     <li>Helicopter overcapacity in the industry had been running as high as 20% before April's crash of a vehicle operated by rival CHC Group off the coast of Norway led to the grounding of the global commercial fleet and the company's bankruptcy filing in May.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200818\" data-linked=\"Bristow warns of full-year loss, cuts capex by 40% over two years\" data-tweet=\"$BRS - Bristow warns of full-year loss, cuts capex by 40% over two years https://seekingalpha.com/news/3200818-bristow-warns-of-full-year-loss-cuts-capex-40-over-two-years?source=tweet\" data-url=\"https://seekingalpha.com/news/3200818-bristow-warns-of-full-year-loss-cuts-capex-40-over-two-years\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:59 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200795\" data-ts=\"1470423377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CS\" target=\"_blank\">CS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200795-report-citigroup-buys-credit-default-swap-portfolio-from-credit-suisse\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Report: Citigroup buys credit-default swap portfolio from Credit Suisse</a></h4><ul>   <li>Citigroup (<a href='https://seekingalpha.com/symbol/C' title='Citigroup Inc.'>C</a> <font color='green'>+3.5%</font>) is the buyer of a <a href=\"http://www.bloomberg.com/news/articles/2016-08-05/citigroup-said-to-buy-derivatives-portfolio-from-credit-suisse\" target=\"_blank\">portfolio of credit-default swaps</a> from Credit Suisse (NYSE:<a href='https://seekingalpha.com/symbol/CS' title='Credit Suisse Group AG'>CS</a>) which is pulling out of some securities businesses in a reshaping, Bloomberg reports.</li>    <li>The gross notional value of the portfolio is said to be about $380B, and last week Credit Suisse said selling it would reduce its leverage exposure by $5B.</li>    <li>Citigroup had bought a similar batch of credit derivatives (about $250B in notional value) from Deutsche Bank last year, and it has more total derivatives than any other U.S. lender.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200795\" data-linked=\"Report: Citigroup buys credit-default swap portfolio from Credit Suisse\" data-tweet=\"$CS $CS $C - Report: Citigroup buys credit-default swap portfolio from Credit Suisse https://seekingalpha.com/news/3200795-report-citigroup-buys-credit-default-swap-portfolio-from-credit-suisse?source=tweet\" data-url=\"https://seekingalpha.com/news/3200795-report-citigroup-buys-credit-default-swap-portfolio-from-credit-suisse\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:56 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>12&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200793\" data-ts=\"1470422678\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RF\" target=\"_blank\">RF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200793-regions-financial-settling-federal-probe-of-fha-mortgages\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Regions Financial settling federal probe of FHA mortgages</a></h4><ul>   <li>Regions Financial (<a href=\"https://seekingalpha.com/symbol/RF\" title=\"Regions Financial Corporation\">RF</a> <font color=\"green\">+4%</font>) has agreed on settlement terms to <a href=\"http://www.reuters.com/article/us-regions-fincl-settlement-idUSKCN10G20O\" target=\"_blank\">resolve a Justice Dept. probe</a> of its mortgage loans.</li>    <li>The agreement won't have a material impact on results or cash flows, the company says.</li>    <li>The lender joins more than a dozen others who settled claims with the DOJ related to FHA-insured home loans. Wells Fargo reached a settlement worth $1.2B on the matter in February.</li>    <li>The Justice Dept. had been looking into Regions' origination, underwriting and quality control practices.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200793\" data-linked=\"Regions Financial settling federal probe of FHA mortgages\" data-tweet=\"$RF - Regions Financial settling federal probe of FHA mortgages https://seekingalpha.com/news/3200793-regions-financial-settling-federal-probe-of-fha-mortgages?source=tweet\" data-url=\"https://seekingalpha.com/news/3200793-regions-financial-settling-federal-probe-of-fha-mortgages\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:44 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200791\" data-ts=\"1470421080\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200791-analysts-failed-clinical-trial-cost-bristol-myers-4b-in-lost-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts: Failed clinical trial could cost Bristol-Myers $4B in lost sales</a></h4><ul>     <li>Analysts say the <a href=\"https://seekingalpha.com/news/3200689-bristol-myers-says-lung-cancer-drug-failed-meet-primary-endpoint\" target=\"_blank\">failed clinical trial</a> for Bristol-Myers Squibb's (<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> <font color=\"red\">-15.8%</font>) blockbuster cancer drug Opdivo as a therapy for newly diagnosed patients with advanced non-small cell lung cancer is a \"<a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/08/05/bristol-myers-squibb-a-4-billion-disaster/\" target=\"_blank\">worst case scenario</a>\u201d that could cost the company as much as $4B in lost sales.</li>     <li>Morgan Stanley <a href=\"http://thefly.com/landingPageNews.php?id=2414342&amp;headline=BMY;MRK-Morgan-Stanley-downgrades-BristolMyers-cuts-target-to--from-\" target=\"_blank\">downgrades</a> BMY to Equal Weight from Overweight and cuts its stock price target to $63 from $81 following the \"surprising\" clinical trial failure, chopping its 2020 Opdivo revenue estimate by 28% to $8.1B and declaring Merck (<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a> <font color=\"green\">+7.8%</font>) the new leader in first-line lung cancer treatment.</li>     <li>However, it is worth noting that BMY has a <a href=\"http://www.wsj.com/articles/how-bristol-myers-survives-a-failure-1470408323\" target=\"_blank\">strong balance sheet</a>, the company has many trials underway studying how to best use its immunotherapies, and perhaps most important, BMY and analysts need to dig into trial data to <a href=\"http://blogs.barrons.com/stockstowatchtoday/2016/08/05/bristol-myers-all-is-not-lost/\" target=\"_blank\">find out what went wrong</a> with the study and why MRK\u2019s Keytruda succeeded; Evercore's Mark Schoenebaum speculates it could be that BMY included a much boarder patient population in its study, while MRK focused on a narrower group of patients.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200791\" data-linked=\"Analysts: Failed clinical trial could cost Bristol-Myers $4B in lost sales\" data-tweet=\"$BMY $BMY $MRK - Analysts: Failed clinical trial could cost Bristol-Myers $4B in lost sales https://seekingalpha.com/news/3200791-analysts-failed-clinical-trial-cost-bristol-myers-4b-in-lost-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3200791-analysts-failed-clinical-trial-cost-bristol-myers-4b-in-lost-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:18 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200790\" data-ts=\"1470420544\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200790-energy-materials-top-5-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm</a></h4><ul> <li>\n<b>Gainers:</b> MPET <font color=\"green\">+15%</font>. <a href=\"https://seekingalpha.com/symbol/OAS\" title=\"Oasis Petroleum Inc.\">OAS</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/MXC\" title=\"Mexco Energy Corporation\">MXC</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/CLMT\" title=\"Calumet Specialty Products Partners, L.P.\">CLMT</a> <font color=\"green\">+9%</font>. <a href=\"https://seekingalpha.com/symbol/MCEP\" title=\"Mid-Con Energy Partners\">MCEP</a> <font color=\"green\">+10%</font>.</li> <li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/SAEX\" title=\"SAExploration Holdings, Inc.\">SAEX</a> <font color=\"red\">-12%</font>. BBG <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/TRX\" title=\"Tanzanian Royalty Exploration Corp.\">TRX</a> <font color=\"red\">-8%</font>. PGH <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/TGC\" title=\"Tengasco, Inc\">TGC</a> <font color=\"red\">-7%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3200790\" data-linked=\"Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm\" data-tweet=\"$TELL $OAS $MXC - Energy/Materials - Top 5 Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3200790-energy-materials-top-5-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3200790-energy-materials-top-5-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:09 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200785\" data-ts=\"1470419278\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SBUX\" target=\"_blank\">SBUX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200785-rbc-capital-weighs-in-on-starbucks\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">RBC Capital weighs in on Starbucks</a></h4><ul> <li>RBC Capital expects Starbucks (<a href=\"https://seekingalpha.com/symbol/SBUX\" title=\"Starbucks Corporation\">SBUX</a> <font color=\"green\">+0.9%</font>) to return to 5% same-store sales growth in the the U.S. as the company improves the execution of its updated My Starbucks Rewards program.</li> <li>The investment firm pulls back on its profit expectation for Starbucks, now seeing EPS of $2.15 vs. $2.20. A higher level wages higher across the chain's workforce is the cause of the downward revision.</li> <li>SBUX currently trades at 25.99X the RBC 2017 EPS estimate.</li>\n<li>Source: <a href=\"http://www.spcapitaliq.com/\" target=\"_blank\">S&amp;P Capital IQ</a>\n</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3200785\" data-linked=\"RBC Capital weighs in on Starbucks\" data-tweet=\"$SBUX - RBC Capital weighs in on Starbucks https://seekingalpha.com/news/3200785-rbc-capital-weighs-in-on-starbucks?source=tweet\" data-url=\"https://seekingalpha.com/news/3200785-rbc-capital-weighs-in-on-starbucks\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200784\" data-ts=\"1470419238\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SSP\" target=\"_blank\">SSP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200784-scripps-down-4_1-q2-revenues-miss\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Scripps down 4.1% as Q2 revenues miss</a></h4><ul>   <li>E.W. Scripps (NASDAQ:<a href=\"https://seekingalpha.com/symbol/SSP\" title=\"The E.W. Scripps Company\">SSP</a>) is trading <font color=\"red\">4.1% lower</font> after <a href=\"https://seekingalpha.com/news/3200649-e-w-scripps-reports-q2-results\" target=\"_blank\">Q2 revenues</a> missed expectations despite 15% growth paced by solid TV growth.</li>    <li>The company swung to a gain on net income. Retransmission revenues rose 46% to $53.4M.</li>    <li>Political TV advertising was $8.4M in Q2 and the company notes spending is focused on key states for Scripps (Ohio, Florida, Colorado, Nevada, Wisconsin).</li>    <li>Revenues by segment: Television, $191.7M (up 14.5%); Radio, $18.2M (down 6.3%); Digital, $15.2M (up 76.8%); Syndication and other, $2.7M (down 1.6%).</li>    <li>Earnings by segment: Television, $53.3M (up 19.5%); Radio, $3.9M (down 20.5%); Digital, -$4.7M (improved from loss of $4.92M); Syndication and other, -$1.05M (improved from loss of $1.06M).</li>    <li>For Q3, Scripps sees TV revenues up between 35% and 45%, with expenses up in the mid-teens; radio revenue down in mid-single digits, with expenses up mid-single digits; and digital revenue up about 50% (with expenses rising by the same ratio).</li>      </ul><div class=\"tiny-share-widget\" data-id=\"3200784\" data-linked=\"Scripps down 4.1% as Q2 revenues miss\" data-tweet=\"$SSP - Scripps down 4.1% as Q2 revenues miss https://seekingalpha.com/news/3200784-scripps-down-4_1-q2-revenues-miss?source=tweet\" data-url=\"https://seekingalpha.com/news/3200784-scripps-down-4_1-q2-revenues-miss\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:47 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200781\" data-ts=\"1470418537\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LOCK\" target=\"_blank\">LOCK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200781-reuters-lifelock-hires-evercore-partners-to-explore-strategic-alternatives-possible-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: LifeLock hires Evercore Partners to explore strategic alternatives, possible sale</a></h4><ul><li>LifeLock (<a href='https://seekingalpha.com/symbol/LOCK' title='LifeLock, Inc.'>LOCK</a> <font color='green'>+6.2%</font>) has <a href=\"http://www.reuters.com/article/us-lifelock-m-a-idUSKCN10G1PZ\" target=\"_blank\">reportedly</a> hired Evercore Partners in a move to defend against activist Elliott Management, which <a href=\"https://seekingalpha.com/news/3189299-lifelock-gains-activist-elliott-discloses-stake-talks-management\" target=\"_blank\">holds an 8.8%&nbsp;stake</a> in the company, and examine undisclosed strategic options.</li><li>Elliot Management <a href=\"http://www.sec.gov/Archives/edgar/data/904495/000101359416001106/lifelock13d-061616.htm\" target=\"_blank\">took a position</a> in LifeLock back in June citing shares of the company were undervalued.</li><li>LifeLock is gaining on the news and is now&nbsp;<font color='green'>up 47%</font>&nbsp;on a 3-month basis.</li></ul><div class=\"tiny-share-widget\" data-id=\"3200781\" data-linked=\"Reuters: LifeLock hires Evercore Partners to explore strategic alternatives, possible sale\" data-tweet=\"$LOCK - Reuters: LifeLock hires Evercore Partners to explore strategic alternatives, possible sale https://seekingalpha.com/news/3200781-reuters-lifelock-hires-evercore-partners-to-explore-strategic-alternatives-possible-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3200781-reuters-lifelock-hires-evercore-partners-to-explore-strategic-alternatives-possible-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:35 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200779\" data-ts=\"1470417190\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/QRTEA\" target=\"_blank\">QRTEA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200779-liberty-interactiveminus-18_3-u-s-sales-begin-tumbling\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Liberty Interactive -18.3% as U.S. sales begin tumbling</a></h4><ul>   <li>Liberty Interactive (QVCA) has <font color=\"red\">dived 18.3%</font> after it warned of \"significant headwinds\" while <a href=\"https://seekingalpha.com/news/3200683-liberty-interactive-reports-q2-results\" target=\"_blank\">reporting Q2 earnings</a> that showed consolidated growth that started to slow in the U.S. with a \"choppy\" retail environment.</li>    <li>QVC Group revenues rose 21% to $2.4B, though operating income fell 11% to $254M. QVC revenue rose 3%, and operating income increased 4%. At recently acquired zulily, revenues grew 23% to $366M.</li>    <li>U.S. sales hit a wall in June, the company said, with declines in mid- to high single digits. It's working on a reversal, but \"even if these initiatives begin to reverse these trends, it is believed that QVC\u2019s US net revenue and adjusted OIBDA will likely experience negative growth rates for the third quarter.\"</li>    <li>At the parent level, Liberty Interactive closed its investment in Liberty Broadband (with the closing of the Charter/TWC merger), <a href=\"https://seekingalpha.com/news/3195307-liberty-wraps-spin-commercehub-unit\" target=\"_blank\">finished a spin-off of CommerceHub</a> and is making progress on the split of Liberty Expedia.</li>     </ul><div class=\"tiny-share-widget\" data-id=\"3200779\" data-linked=\"Liberty Interactive -18.3% as U.S. sales begin tumbling\" data-tweet=\"$QRTEA - Liberty Interactive -18.3% as U.S. sales begin tumbling https://seekingalpha.com/news/3200779-liberty-interactiveminus-18_3-u-s-sales-begin-tumbling?source=tweet\" data-url=\"https://seekingalpha.com/news/3200779-liberty-interactiveminus-18_3-u-s-sales-begin-tumbling\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200776\" data-ts=\"1470416406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200776-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/AHT\" title=\"Ashford Hospitality Trust, Inc.\">AHT</a> <font color=\"green\">+14%</font>. <a href=\"https://seekingalpha.com/symbol/KMPR\" title=\"Kemper Corporation\">KMPR</a> <font color=\"green\">+10%</font>. <a href=\"https://seekingalpha.com/symbol/EHTH\" title=\"eHealth, Inc.\">EHTH</a> <font color=\"green\">+8%</font>. <a href=\"https://seekingalpha.com/symbol/GNBC\" title=\"Green Bancorp\">GNBC</a> <font color=\"green\">+7%</font>. <a href=\"https://seekingalpha.com/symbol/WMC\" title=\"Western Asset Mortgage Capital Corporation\">WMC</a> <font color=\"green\">+7%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/ECPG\" title=\"Encore Capital Group Inc\">ECPG</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/NNI\" title=\"Nelnet, Inc.\">NNI</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/SIEB\" title=\"Siebert Financial Corp.\">SIEB</a> <font color=\"red\">-8%</font>. <a href=\"https://seekingalpha.com/symbol/RBS\" title=\"The Royal Bank of Scotland Group plc\">RBS</a> <font color=\"red\">-7%</font>. <a href=\"https://seekingalpha.com/symbol/ZG\" title=\"Zillow Group, Inc.\">ZG</a> <font color=\"red\">-7%.</font>\n</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200776\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$AHT $KMPR $EHTH - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3200776-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3200776-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200778\" data-ts=\"1470416242\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AET\" target=\"_blank\">AET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200778-judge-bates-to-hear-aetna-humana-merger-case-hands-off-on-anthem-cigna\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Judge Bates to hear Aetna-Humana merger case, hands off on Anthem-Cigna</a></h4><ul>     <li>The judge overseeing two U.S. cases challenging mergers among four of the biggest health insurers gave up one, saying he <a href=\"http://www.bloomberg.com/news/articles/2016-08-05/aetna-judge-hands-off-anthem-antitrust-case-to-speed-trials\" target=\"_blank\">will keep the case</a> against Aetna's (<a href=\"https://seekingalpha.com/symbol/AET\" title=\"Aetna, Inc.\">AET</a> <font color=\"green\">+2.4%</font>) deal for Humana (<a href=\"https://seekingalpha.com/symbol/HUM\" title=\"Humana Inc.\">HUM</a> <font color=\"green\">+2.8%</font>) while leaving the challenge to Anthem\u2019s (<a href=\"https://seekingalpha.com/symbol/ANTM\" title=\"Anthem, Inc.\">ANTM</a> <font color=\"green\">+0.7%</font>) takeover of Cigna (<a href=\"https://seekingalpha.com/symbol/CI\" title=\"Cigna Corporation\">CI</a> <font color=\"red\">-0.1%</font>) to another judge.</li>     <li>The decision is seen improving the odds for rulings on both mergers by year-end and lowering the chance that they fall apart beforehand.</li>     <li>Judge Bates, a Republican who has ruled against the government in the past and has voiced skepticism of various Justice Department actions, is considered more favorable towards the proposed  AET-HUM deal, while the judge assigned to the ANTM-CI case is a Democrat appointed to the bench by Pres. Obama.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200778\" data-linked=\"Judge Bates to hear Aetna-Humana merger case, hands off on Anthem-Cigna\" data-tweet=\"$AET $AET $HUM - Judge Bates to hear Aetna-Humana merger case, hands off on Anthem-Cigna https://seekingalpha.com/news/3200778-judge-bates-to-hear-aetna-humana-merger-case-hands-off-on-anthem-cigna?source=tweet\" data-url=\"https://seekingalpha.com/news/3200778-judge-bates-to-hear-aetna-humana-merger-case-hands-off-on-anthem-cigna\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:57 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200773\" data-ts=\"1470415607\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200773-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers /Losers</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/SHIP\" title=\"Seanergy Maritime Holdings Corp\">SHIP</a> <font color=\"green\">+58%</font>. <a href=\"https://seekingalpha.com/symbol/SINO\" title=\"Sino-Global Shipping America, Ltd.\">SINO</a> <font color=\"green\">+53%</font>. <a href=\"https://seekingalpha.com/symbol/LNTH\" title=\"Lantheus Holdings\">LNTH</a> <font color=\"green\">+51%</font>. <a href=\"https://seekingalpha.com/symbol/PTCT\" title=\"PTC Therapeutics\">PTCT</a> <font color=\"green\">+29%</font>. <a href=\"https://seekingalpha.com/symbol/FRPT\" title=\"Freshpet\">FRPT</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/MNTA\" title=\"Momenta Pharmaceuticals, Inc.\">MNTA</a> <font color=\"green\">+25%</font>. <a href=\"https://seekingalpha.com/symbol/WLDN\" title=\"Willdan Group, Inc.\">WLDN</a> <font color=\"green\">+23%</font>. <a href=\"https://seekingalpha.com/symbol/OCUL\" title=\"Ocular Therapeutix\">OCUL</a> <font color=\"green\">+19%</font>. <a href=\"https://seekingalpha.com/symbol/SPXC\" title=\"SPX Corporation\">SPXC</a> <font color=\"green\">+18%</font>. <a href=\"https://seekingalpha.com/symbol/KTOS\" title=\"Kratos Defense &amp; Security Solutions, Inc.\">KTOS</a> <font color=\"green\">+18%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/CPSI\" title=\"Computer Programs and Systems, Inc.\">CPSI</a> <font color=\"red\">-30%</font>. <a href=\"https://seekingalpha.com/symbol/HDP\" title=\"Hortonworks\">HDP</a> <font color=\"red\">-28%</font>. <a href=\"https://seekingalpha.com/symbol/IMI\" title=\"Intermolecular, Inc.\">IMI</a> <font color=\"red\">-26%</font>. <a href=\"https://seekingalpha.com/symbol/INUV\" title=\"Inuvo, Inc\">INUV</a> <font color=\"red\">-20%</font>. <a href=\"https://seekingalpha.com/symbol/SWIR\" title=\"Sierra Wireless, Inc.\">SWIR</a> <font color=\"red\">-19%</font>. <a href=\"https://seekingalpha.com/symbol/XCOM\" title=\"Xtera Communications\">XCOM</a> <font color=\"red\">-18%</font>. QVCA <font color=\"red\">-16%</font>. <a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> <font color=\"red\">-15%</font>. <a href=\"https://seekingalpha.com/symbol/ECPG\" title=\"Encore Capital Group Inc\">ECPG</a> <font color=\"red\">-14%</font>. <a href=\"https://seekingalpha.com/symbol/UTI\" title=\"Universal Technical Institute\">UTI</a> <font color=\"red\">-14%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200773\" data-linked=\"Midday Gainers /Losers\" data-tweet=\"$SHIP $SINO $LNTH - Midday Gainers /Losers https://seekingalpha.com/news/3200773-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3200773-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:46 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200772\" data-ts=\"1470415531\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ZNGA\" target=\"_blank\">ZNGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200772-zyngaminus-7_2-after-revenue-miss-light-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zynga -7.2% after revenue miss, light guidance</a></h4><ul>   <li>After hitting a 52-week high yesterday, Zynga (NASDAQ:<a href=\"https://seekingalpha.com/symbol/ZNGA\" title=\"Zynga\">ZNGA</a>) is <font color=\"red\">7.2% lower</font> today following a <a href=\"https://seekingalpha.com/news/3200265-zynga-minus-9_8-percent-revenue-users-fall-q2\" target=\"_blank\">Q2 revenue miss</a> that featured some downbeat news on its bookings.</li>    <li>Bookings (recognized revenue plus the change in deferred revenue) fell 4% from the first quarter, to $175M. The company guided Q3 bookings for $180M-$190M, along with revenue of $170M-$180M (below consensus for $183.9M).</li>    <li>That <a href=\"http://www.streetinsider.com/Analyst+Comments/Zynga+%28ZNGA%29+Guidance+Looks+Conservative+-+Jefferies/11907153.html\" target=\"_blank\">guidance looks conservative</a>, Jefferies says in reiterating its Buy rating and $5 price target (implying 81% upside from today's $2.76): \"By year-end we believe user metrics (which have mostly stabilized) could begin to inflect upwards for the first time in years. We note ZNGA does not need a breakout hit to drive growth and profitability and we continue to think the risk/reward looks attractive at these levels especially with $1.25 per share in cash, investments, and real estate.\"</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200772\" data-linked=\"Zynga -7.2% after revenue miss, light guidance\" data-tweet=\"$ZNGA - Zynga -7.2% after revenue miss, light guidance https://seekingalpha.com/news/3200772-zyngaminus-7_2-after-revenue-miss-light-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3200772-zyngaminus-7_2-after-revenue-miss-light-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:45 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200763\" data-ts=\"1470412847\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200763-consumer-goods-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer Goods - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li>\n<b>Gainers:</b> <a href=\"https://seekingalpha.com/symbol/FRPT\" title=\"Freshpet\">FRPT</a> <font color=\"green\">+27%</font>. <a href=\"https://seekingalpha.com/symbol/SUMR\" title=\"Summer Infant, Inc.\">SUMR</a> <font color=\"green\">+16%</font>. <a href=\"https://seekingalpha.com/symbol/NUS\" title=\"Nu Skin Enterprises Inc.\">NUS</a> <font color=\"green\">+12%</font>. <a href=\"https://seekingalpha.com/symbol/ICON\" title=\"Iconix Brand Group, Inc.\">ICON</a> <font color=\"green\">+11%</font>. <a href=\"https://seekingalpha.com/symbol/CXDC\" title=\"China XD Plastics Company Limited\">CXDC</a> <font color=\"green\">+9%</font>.</li>\n<li>\n<b>Losers:</b> <a href=\"https://seekingalpha.com/symbol/TOF\" title=\"Tofutti Brands Inc\">TOF</a> <font color=\"red\">-10%</font>. <a href=\"https://seekingalpha.com/symbol/UEIC\" title=\"Universal Electronics Inc.\">UEIC</a> <font color=\"red\">-5%</font>. SPU <font color=\"red\">-5%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200763\" data-linked=\"Consumer Goods - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$FRPT $SUMR $NUS - Consumer Goods - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3200763-consumer-goods-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3200763-consumer-goods-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:00 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200765\" data-ts=\"1470412786\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SUN\" target=\"_blank\">SUN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200765-sunoco-downgraded-baird-distribution-growth-threatened\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sunoco downgraded at Baird as distribution growth threatened</a></h4><ul>     <li>Sunoco (<a href=\"https://seekingalpha.com/symbol/SUN\" title=\"Sunoco LP\">SUN</a> <font color=\"green\">+1.8%</font>) is <a href=\"http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8312573/baird-stops-defending-sunoco-downgrades-to-neutral\" target=\"_blank\">downgraded</a> to Neutral from Outperform with a $30 price target, slashed from $43, at Baird, which says it is waiting for improvement in leverage and volumes.</li>\n<li>Baird says it has defended SUN on the premise that margins would improve, which was affirmed in the company's <a href=\"https://seekingalpha.com/news/3199706-sunoco-lp-beats-0_08-misses-revenue\" target=\"_blank\">Q2 earnings</a> report, but a 13% disconnect from its volume forecast ultimately drove a  23% miss vs. the firm's DCF/unit target, netting to uninspiring 0.95x coverage.</li>\n<li>The firm thinks much tighter leverage threatens meaningful distribution growth, and precipitates either equity issuance or a distribution haircut.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200765\" data-linked=\"Sunoco downgraded at Baird as distribution growth threatened\" data-tweet=\"$SUN - Sunoco downgraded at Baird as distribution growth threatened https://seekingalpha.com/news/3200765-sunoco-downgraded-baird-distribution-growth-threatened?source=tweet\" data-url=\"https://seekingalpha.com/news/3200765-sunoco-downgraded-baird-distribution-growth-threatened\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:59 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200760\" data-ts=\"1470411934\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CNP\" target=\"_blank\">CNP</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200760-centerpoint-energy-rejects-reit-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">CenterPoint Energy rejects REIT plan</a></h4><ul>     <li>CenterPoint Energy (<a href='https://seekingalpha.com/symbol/CNP' title='CenterPoint Energy, Inc.'>CNP</a> <font color='red'>-2.5%</font>) says it will <a href=\"http://fuelfix.com/blog/2016/08/05/centerpoint-rejects-reit-plan-as-it-reports-2-million-loss\" target=\"_blank\">no longer pursue forming a REIT</a> structure for its utility business, deciding that the potential to create long-term shareholder value via a REIT is \"very limited and does not justify exposure to the associated risks.\"</li>     <li>In reporting smaller than expected <a href=\"https://seekingalpha.com/news/3200620-centerpoint-misses-0_03-misses-revenue\" target=\"_blank\">Q2 earnings</a>, CNP says its natural gas business was hurt by a mild winter that reduced&nbsp;gas demand, and results were weighed down by its Enable Midstream Partners (<a href='https://seekingalpha.com/symbol/ENBL' title='Enable Midstream Partners LP'>ENBL</a> <font color='green'>+2.5%</font>) joint venture, which also posted below consensus <a href=\"https://seekingalpha.com/news/3199091-enable-midstream-misses-0_10-misses-revenue\" target=\"_blank\">Q2 earnings</a>.</li>     <li>Fellow ENBL partner OGE Energy (<a href='https://seekingalpha.com/symbol/OGE' title='OGE Energy Corp.'>OGE</a> <font color='red'>-0.9%</font>) said <a href=\"https://seekingalpha.com/news/3199850-oge-energy-misses-0_06-misses-revenue\" target=\"_blank\">yesterday</a> that CNP is offering to sell its ENBL stake to OGE.</li>     <li>CNP  also reaffirms guidance FY 2016 EPS guidance of $1.12-$1.20 vs. $1.15 analyst consensus estimate.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200760\" data-linked=\"CenterPoint Energy rejects REIT plan\" data-tweet=\"$CNP $CNP $ENBL - CenterPoint Energy rejects REIT plan https://seekingalpha.com/news/3200760-centerpoint-energy-rejects-reit-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3200760-centerpoint-energy-rejects-reit-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200757\" data-ts=\"1470411158\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/OLED\" target=\"_blank\">OLED</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200757-universal-displayminus-10-on-unconvincing-quarter-and-reduced-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Universal Display -10% on unconvincing quarter and reduced guidance</a></h4><ul>\n<li>Universal Display (<a href=\"https://seekingalpha.com/symbol/OLED\" title=\"Universal Display Corporation\">OLED</a> <font color=\"red\">-9.8%</font>) <a href=\"https://seekingalpha.com/news/3200257-universal-display-misses-0_04-misses-revenue\" target=\"_blank\">reported</a> lower-than-expected top and bottom-line figures in its Q2 report and although revenue was up 10.8% against the year-ago period, management forecasts upcoming near-term revenue pressure.</li>\n<li>Executive Vice President and CFO Sidney Rosenblatt: \"Our second quarter 2016 revenues and net income increased year-over-year, and we maintained our strong margin profile. We are confident that the underlying growth fundamentals of our long-term outlook remain robust, but near-term, we expect our revenue growth will be delayed by about six months.\"</li>\n<li>The company accordingly revises its revenue guidance for FY 2016 to $190M-$200M.</li>\n<li><a href=\"https://seekingalpha.com/article/3996161-universal-displays-oled-ceo-steve-abramson-q2-2016-results-earnings-call-transcript\" target=\"_blank\">Earnings call transcript</a></li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200757\" data-linked=\"Universal Display -10% on unconvincing quarter and reduced guidance\" data-tweet=\"$OLED - Universal Display -10% on unconvincing quarter and reduced guidance https://seekingalpha.com/news/3200757-universal-displayminus-10-on-unconvincing-quarter-and-reduced-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3200757-universal-displayminus-10-on-unconvincing-quarter-and-reduced-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200758\" data-ts=\"1470410933\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZN\" target=\"_blank\">AZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200758-astrazeneca-hits-52-week-high-helped-bristol-myers-drug-failure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AstraZeneca hits 52-week high, helped by Bristol-Myers drug failure</a></h4><ul>     <li>AstraZeneca (<a href=\"https://seekingalpha.com/symbol/AZN\" title=\"AstraZeneca Group plc\">AZN</a> <font color=\"green\">+1.2%</font>) shoots to a 52-week high, as the <a href=\"https://seekingalpha.com/news/3200689-bristol-myers-says-lung-cancer-drug-failed-meet-primary-endpoint\" target=\"_blank\">failure</a> of Bristol-Myers Squibb's (<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a> <font color=\"red\">-16.7%</font>) immunotherapy drug Opdivo to slow disease progression in previously untreated patients with lung cancer was viewed by investors as <a href=\"http://www.reuters.com/article/us-astrazeneca-cancer-idUSKCN10G1L6\" target=\"_blank\">good news for rivals</a> AZN and Merck (<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a> <font color=\"green\">+6.7%</font>).</li>     <li>Analysts at Leerink, Jefferies and Deutsche Bank say the news increases the potential market opportunity for AZN's combination of durvalumab and tremelimumab.</li>     <li>Cancer is the hottest area of research across the drug industry, which some analysts believe could make AZN a takeover target again, with <a href=\"https://seekingalpha.com/news/3197264-astrazeneca-6-percent-rumored-novartis-interest\" target=\"_blank\">speculation</a> recently turning to Novartis as a bidder.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200758\" data-linked=\"AstraZeneca hits 52-week high, helped by Bristol-Myers drug failure\" data-tweet=\"$AZN $AZN $BMY - AstraZeneca hits 52-week high, helped by Bristol-Myers drug failure https://seekingalpha.com/news/3200758-astrazeneca-hits-52-week-high-helped-bristol-myers-drug-failure?source=tweet\" data-url=\"https://seekingalpha.com/news/3200758-astrazeneca-hits-52-week-high-helped-bristol-myers-drug-failure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200752\" data-ts=\"1470409809\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/Z\" target=\"_blank\">Z</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200752-zillow-down-6-net-loss-and-litigation-expenses-impact-sentiment\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Zillow down 6%; net loss and litigation expenses impact sentiment</a></h4><ul><li>Zillow, (<a href=\"https://seekingalpha.com/symbol/Z/focus\" target=\"_blank\">Z</a>, <a href=\"https://seekingalpha.com/symbol/ZG/earnings_news\" target=\"_blank\">ZG</a>) <a href=\"https://seekingalpha.com/news/3200385-zillow-eps-0_87\" target=\"_blank\">posted</a> Q2 results yesterday with a 21% Y/Y increase in revenue and an all-time high of over 171M unique visitors, but eyes have shifted to continued net losses and steep legal expenses.</li><li>The company reported GAAP net loss of $156.1M vs. a net loss of $38.7M for the same period last year. The majority of this quarter's figure is attributed to $142.5M in litigation settlement expenses.</li><li>Adjusted EBITDA was -$101.3M vs. $21M in Q2 2015. This figure is similarly attributed to legal costs. Excluding the litigation impact, adjusted EBITDA would have been $28.7M.</li><li>Investors, though, are not interested in what would have been as the company continues to trade lower following the report.</li><li>Zillow Group-A (<a href=\"https://seekingalpha.com/symbol/ZG/focus\" target=\"_blank\">ZG</a>) shares are up&nbsp;<font color='green'>more than 30%</font>&nbsp;on a 3-month basis and&nbsp;<font color='green'>more than 40%</font>&nbsp;on a 1-year basis. Group-C (<a href=\"https://seekingalpha.com/symbol/Z/focus\" target=\"_blank\">Z</a>) shares are&nbsp;<font color='green'>up nearly 40%</font>&nbsp;and&nbsp;<font color='green'>more than 45%</font>&nbsp;on a 3-month and 1-year basis, respectively.</li></ul><div class=\"tiny-share-widget\" data-id=\"3200752\" data-linked=\"Zillow down 6%; net loss and litigation expenses impact sentiment\" data-tweet=\"$Z $Z $ZG - Zillow down 6%; net loss and litigation expenses impact sentiment https://seekingalpha.com/news/3200752-zillow-down-6-net-loss-and-litigation-expenses-impact-sentiment?source=tweet\" data-url=\"https://seekingalpha.com/news/3200752-zillow-down-6-net-loss-and-litigation-expenses-impact-sentiment\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:10 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200742\" data-ts=\"1470409206\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200742-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/LNTH' title='Lantheus Holdings'>LNTH</a> <font color='green'>+47%</font>. <a href='https://seekingalpha.com/symbol/OCUL' title='Ocular Therapeutix'>OCUL</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/PTCT' title='PTC Therapeutics'>PTCT</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/OVAS-OLD' title='OvaScience, Inc.'>OVAS-OLD</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/MNTA' title='Momenta Pharmaceuticals, Inc.'>MNTA</a> <font color='green'>+13%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/PDLI' title='PDL BioPharma, Inc.'>PDLI</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/FLDM' title='Fluidigm Corporation'>FLDM</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/NTRA' title='Natera'>NTRA</a> <font color='red'>-13%</font>. <a href='https://seekingalpha.com/symbol/CARA' title='Cara Therapeutics Inc.'>CARA</a> <font color='red'>-11%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3200742\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$LNTH $OCUL $PTCT - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3200742-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3200742-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:00 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200749\" data-ts=\"1470408208\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SEDG\" target=\"_blank\">SEDG</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200749-teslas-musk-plans-to-go-own-way-dropping-solaredge-inverters\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tesla&#39;s Musk plans to go his own way, dropping SolarEdge inverters</a></h4><ul>     <li>Shares of SolarEdge Technologies (<a href=\"https://seekingalpha.com/symbol/SEDG\" title=\"SolarEdge Technologies\">SEDG</a> <font color=\"green\">+3.4%</font>) are rebounding from yesterday's 4.5% drubbing that followed comments from Tesla (<a href=\"https://seekingalpha.com/symbol/TSLA\" title=\"Tesla, Inc.\">TSLA</a> <font color=\"red\">-1%</font>) CEO Elon Musk that his company would <a href=\"http://www.bloomberg.com/news/articles/2016-08-04/tesla-s-grand-plans-for-solarcity-burn-a-key-israeli-solar-tech-firm\" target=\"_blank\">build its own power inverters</a> to be integrated with home batteries and rooftop solar systems.</li>     <li>Musk says \"There's no question Tesla's going to do integrated inverter... We've got the most advanced inverter engineering team in the world, and so it makes sense to, just as we do the inverters on vehicles, to do it with solar as well and have it in a  very tight package at a cents-per-watt level that is I think probably twice as good as anyone else.\"</li>     <li>SEDG fell as much as 6.9% yesterday before  recouping part of the losses; shares have shed  22% since Musk first disclosed his interest in SolarCity on June 21.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200749\" data-linked=\"Tesla&#39;s Musk plans to go his own way, dropping SolarEdge inverters\" data-tweet=\"$SEDG $SEDG $TSLA - Tesla&#39;s Musk plans to go his own way, dropping SolarEdge inverters https://seekingalpha.com/news/3200749-teslas-musk-plans-to-go-own-way-dropping-solaredge-inverters?source=tweet\" data-url=\"https://seekingalpha.com/news/3200749-teslas-musk-plans-to-go-own-way-dropping-solaredge-inverters\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:43 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>132&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200747\" data-ts=\"1470407680\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FRPT\" target=\"_blank\">FRPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200747-freshpet-flies-after-earnings-and-backing-from-analysts\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Freshpet flies after earnings and backing from analysts</a></h4><ul> <li>Stephens <a href=\"http://www.marketbeat.com/stocks/NASDAQ/FRPT/\" target=\"_blank\">upgrades</a> Freshpet (<a href=\"https://seekingalpha.com/symbol/FRPT\" title=\"Freshpet\">FRPT</a> <font color=\"green\">+26.2%</font>) to Overweight from Equal Weight.</li> <li>Wedbush backs its Outperform rating.</li> <li>The rating actions follows a mixed Q2 report from Freshpet. Guidance from Freshpet is for full-year sales to top $137M and adjusted EBITDA to hit $18.5M.</li> <li>Previously: <a href=\"https://seekingalpha.com/news/3200411-freshpet-misses-0_07-beats-revenue\" target=\"_blank\">Freshpet misses by $0.07, beats on revenue</a> (Aug. 4)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200747\" data-linked=\"Freshpet flies after earnings and backing from analysts\" data-tweet=\"$FRPT - Freshpet flies after earnings and backing from analysts https://seekingalpha.com/news/3200747-freshpet-flies-after-earnings-and-backing-from-analysts?source=tweet\" data-url=\"https://seekingalpha.com/news/3200747-freshpet-flies-after-earnings-and-backing-from-analysts\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200736\" data-ts=\"1470405143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIVE\" target=\"_blank\">FIVE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200736-five-below-on-move-after-ubs-tips-pokemon-lift\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Five Below on the move after UBS tips Pokémon lift</a></h4><ul> <li>Five Below (NASDAQ:<a href=\"https://seekingalpha.com/symbol/FIVE\" title=\"Five Below\">FIVE</a>) is <font color=\"green\">up 4%</font> in early trading to jump back over $50.</li> <li>UBS is out with some commentary on how the  Pokémon effect for the retailer isn't being appreciated by investors (<a href=\"https://twitter.com/HiddenGemTrader/status/761555079409184774\" target=\"_blank\">h/t Hidden Gem Trades</a>).</li> <li>Presumably, the investment firm is referring to the <a href=\"http://www.fivebelow.com/new-arrivals/pokemon-xy10-cards.html\" target=\"_blank\">assortment</a> of  Pokémon trading cards and accessories it sells.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3200736\" data-linked=\"Five Below on the move after UBS tips Pokémon lift\" data-tweet=\"$FIVE - Five Below on the move after UBS tips Pokémon lift https://seekingalpha.com/news/3200736-five-below-on-move-after-ubs-tips-pokemon-lift?source=tweet\" data-url=\"https://seekingalpha.com/news/3200736-five-below-on-move-after-ubs-tips-pokemon-lift\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:52 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200734\" data-ts=\"1470405067\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RAX\" target=\"_blank\">RAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200734-reuters-apollo-global-management-interested-in-acquiring-rackspace-for-3_5b\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Reuters: Apollo Global Management interested in acquiring Rackspace for $3.5B</a></h4><ul>\n<li>Following yesterday's <a href=\"https://seekingalpha.com/news/3200241-dow-jones-rackspace-takeover-announced-week-shares-plus-18-percent-updated\" target=\"_blank\">report</a> of a possible takeover, Reuters now <a href=\"http://www.reuters.com/article/us-rackspace-m-a-apollo-idUSKCN10G1HL\" target=\"_blank\">asserts</a> Apollo Global Management is the interested private equity party. Sources note a deal has not presently been finalized.</li>\n<li>Rackspace (<a href=\"https://seekingalpha.com/symbol/RAX\" title=\"Rackspace Hosting, Inc.\">RAX</a> <font color=\"green\">+10.1%</font>) is <font color=\"green\">up more than 30%</font> since late in yesterday's trading session.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200734\" data-linked=\"Reuters: Apollo Global Management interested in acquiring Rackspace for $3.5B\" data-tweet=\"$RAX - Reuters: Apollo Global Management interested in acquiring Rackspace for $3.5B https://seekingalpha.com/news/3200734-reuters-apollo-global-management-interested-in-acquiring-rackspace-for-3_5b?source=tweet\" data-url=\"https://seekingalpha.com/news/3200734-reuters-apollo-global-management-interested-in-acquiring-rackspace-for-3_5b\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:51 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200732\" data-ts=\"1470404431\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TPR\" target=\"_blank\">TPR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200732-telsey-advisory-group-sees-upside-for-coach\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Telsey Advisory Group sees upside for Coach</a></h4><ul> <li>Telsey Advisory Group <a href=\"http://www.cnbc.com/2016/08/05/early-movers-coh-ctsh-wltw-pcln-lnkd-atvi-khc-rax-more.html\" target=\"_blank\">shifts</a> to an Outperform rating on Coach (COH <font color=\"green\">+1.3%</font>) after having the retailer set at Market Perform.</li> <li>The investment firm has a brighter short-term outlook for Coach with product and store initiatives looking promising.</li> <li>Shares of Coach are still down 3% for the week after a weak earnings report from Kate Spade influenced sentiment.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3200732\" data-linked=\"Telsey Advisory Group sees upside for Coach\" data-tweet=\"$TPR - Telsey Advisory Group sees upside for Coach https://seekingalpha.com/news/3200732-telsey-advisory-group-sees-upside-for-coach?source=tweet\" data-url=\"https://seekingalpha.com/news/3200732-telsey-advisory-group-sees-upside-for-coach\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:40 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200721\" data-ts=\"1470403604\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MGA\" target=\"_blank\">MGA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200721-on-magna-internationals-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on Magna International&#39;s Q2</a></h4><ul>     <li>Magna International (NYSE:<a href=\"https://seekingalpha.com/symbol/MGA\" title=\"Magna International Inc.\">MGA</a>) reports sales rose 16% in Q2</li>     <li>North American light vehicle production increased 2% to 4.598M units.</li>     <li>European light vehicle production rose 6% to 5.812M units.</li>     <li>Segment sales: North America: $5.317B (+7%); Europe: $3.512B (+36%); Asia: $624M (+20.5%); ROW: $88M (-50%).</li>     <li>Production sales: North America: $4.902B (+7%); Europe: $2.486B (+36%); Asia: $624M (+20.5%); ROW: $88M (-50%).</li>     <li>Complete vehicle assembly sales expanded 7% to $652M, while volume declined 9% to 26,715 units.</li>     <li>Tooling, Engineering and Other Sales up 33% to $797M.</li>     <li>Gross margin rate improved 40 bps to 14.8%.</li>     <li>SG&amp;A expense rate +10 bps to 4.3%.</li>     <li>Adjusted EBIT advanced 17% to $789M.</li>     <li>\n<b>FY2016 Guidance</b>: Light vehicle production (units): North America 18M and Europe 21.4M; Total sales: $35.5B to $37.2B; Complete vehicle assembly sales: $2B to $2.3B; Adjusted EBIT: ~8%; Interest expense, net: ~$90M; Tax rate: 26% to 26%; Capex: $1.8B to $2B.</li>     <li>\n<b>FY2016 Production sales</b>: North America: $19.4B to $20B; Europe: $8.8B to $9.2B; Asia: $2.1B to $2.3B; ROW: $0.3B to $0.4B; Total production sales: $30.6B to $31.9B.</li>     <li>MGA <font color=\"green\">+3.19%</font> premarket.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200721\" data-linked=\"More on Magna International&#39;s Q2\" data-tweet=\"$MGA - More on Magna International&#39;s Q2 https://seekingalpha.com/news/3200721-on-magna-internationals-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3200721-on-magna-internationals-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200723\" data-ts=\"1470403116\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NVO\" target=\"_blank\">NVO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200723-novo-nordiskminus-10-amid-pricing-challenges-in-u-s-market\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novo Nordisk -10% amid pricing challenges in U.S. market</a></h4><ul>     <li>Novo Nordisk (NYSE:<a href=\"https://seekingalpha.com/symbol/NVO\" title=\"Novo Nordisk A/S\">NVO</a>) <font color=\"red\">-9.9%</font> premarket after a mixed <a href=\"https://seekingalpha.com/news/3200641-novo-nordisk-revenues-2-percent-earnings-20-percent-q2-revises-guidance\" target=\"_blank\">Q2 earnings</a> report and cutting its full-year sales and profit forecast, weighed by the loss of a key contract for its top-selling insulin NovoLog.</li>     <li>NVO says its FY 2016 profit likely will <a href=\"http://www.bloomberg.com/news/articles/2016-08-05/novo-trims-full-year-outlook-amid-increasing-u-s-price-pressure\" target=\"_blank\">climb as much as 8%</a> Y/Y, but that's down from an earlier projection of as much as 9% growth; sales for the full year are seen rising as much as 7%, lower than an earlier outlook for as much as 9%.</li>     <li>After completing most of its 2017 negotiations with pharmacy benefits managers for insurance coverage in the U.S., average prices will be \u201clow- to mid-single digit\u201d percentage less than 2016 levels with rebates, CEO Lars Soerensen tells Bloomberg.</li>     <li>NVO says rising revenue from Victoza, a blockbuster medicine that stimulates insulin production, and Tresiba likely will be partly offset by the lost contract for NovoLog this year.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200723\" data-linked=\"Novo Nordisk -10% amid pricing challenges in U.S. market\" data-tweet=\"$NVO - Novo Nordisk -10% amid pricing challenges in U.S. market https://seekingalpha.com/news/3200723-novo-nordiskminus-10-amid-pricing-challenges-in-u-s-market?source=tweet\" data-url=\"https://seekingalpha.com/news/3200723-novo-nordiskminus-10-amid-pricing-challenges-in-u-s-market\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>21&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200719\" data-ts=\"1470402746\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200719-premarket-gainers-losers-of-9-10\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers / Losers as of 9:10 am</a></h4><ul> <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CHEK' title='Check-Cap Ltd.'>CHEK</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/RAX' title='Rackspace Hosting, Inc.'>RAX</a> <font color='green'>+17%</font>. <a href='https://seekingalpha.com/symbol/EGLT' title='Egalet Ltd.'>OTC:EGLT</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/PACB' title='Pacific Biosciences of California'>PACB</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/MRK' title='Merck & Co Inc.'>MRK</a> <font color='green'>+11%</font>. <a href='https://seekingalpha.com/symbol/SAEX' title='SAExploration Holdings, Inc.'>SAEX</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ONVO' title='Organovo Holdings, Inc.'>ONVO</a> <font color='green'>+9%</font>. <a href='https://seekingalpha.com/symbol/GSAT' title='Globalstar, Inc.'>GSAT</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/EHTH' title='eHealth, Inc.'>EHTH</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/SYMC' title='Symantec Corporation'>SYMC</a> <font color='green'>+6%</font>. PCLN <font color='green'>+6%</font>. LGF <font color='green'>+6%</font>.</li> <li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/HDP' title='Hortonworks'>HDP</a> <font color='red'>-33%</font>. <a href='https://seekingalpha.com/symbol/SWIR' title='Sierra Wireless, Inc.'>SWIR</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/BMY' title='Bristol-Myers Squibb Company'>BMY</a> <font color='red'>-18%</font>. <a href='https://seekingalpha.com/symbol/FEYE' title='FireEye, Inc.'>FEYE</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/NVO' title='Novo Nordisk A/S'>NVO</a> <font color='red'>-10%</font>. <a href='https://seekingalpha.com/symbol/DMRC' title='Digimarc Corporation'>DMRC</a> <font color='red'>-9%</font>. <a href='https://seekingalpha.com/symbol/RBS' title='The Royal Bank of Scotland Group plc'>RBS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ZNGA' title='Zynga'>ZNGA</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/CERS' title='Cerus Corporation'>CERS</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3200719\" data-linked=\"Premarket Gainers / Losers as of 9:10 am\" data-tweet=\"$CHEK $RAX $ZCOR - Premarket Gainers / Losers as of 9:10 am https://seekingalpha.com/news/3200719-premarket-gainers-losers-of-9-10?source=tweet\" data-url=\"https://seekingalpha.com/news/3200719-premarket-gainers-losers-of-9-10\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200699\" data-ts=\"1470401198\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200699-futures-and-bond-yields-move-higher-after-jobs-numbers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Futures and bond yields move higher after jobs numbers</a></h4><ul>\n<li>U.S. stock index futures have added to gains after the <a href=\"https://seekingalpha.com/news/3200684-july-jobs-gain-255k-tops-estimates\" target=\"_blank\">better-than-hoped</a> jobs report for July, with the S&amp;P 500 (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/SPY\" title=\"SPDR S&amp;P 500 Trust ETF\">SPY</a>) and Nasdaq 100 (NASDAQ:<a href=\"https://seekingalpha.com/symbol/QQQ\" title=\"PowerShares QQQ Trust ETF\">QQQ</a>) <font color=\"green\">higher by 0.4%</font>, and the Dow (NYSEARCA:<a href=\"https://seekingalpha.com/symbol/DIA\" title=\"SPDR Dow Jones Industrial Average ETF\">DIA</a>) <font color=\"green\">up 0.5%</font>.</li>\n<li>With a September rate hike seemingly much more of a possibility, the 10-year Treasury yield has jumped four basis points to 1.54%. <a href=\"https://seekingalpha.com/symbol/TLT\" title=\"iShares 20+ Year Treasury Bond ETF\">TLT</a><font color=\"red\"> -0.5%</font>, <a href=\"https://seekingalpha.com/symbol/TBT\" title=\"ProShares UltraShort 20+ Year Treasury ETF\">TBT</a> <font color=\"green\">+1%</font>. Fed Funds futures <a href=\"http://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">are still pricing in</a> just about a 50% chance of one rate hike this year.</li>\n<li>Gold has <font color=\"red\">dipped about $10</font> per ounce. <a href=\"https://seekingalpha.com/symbol/GLD\" title=\"SPDR Gold Trust ETF\">GLD</a> <font color=\"red\">-1%</font>\n</li>\n<li>The dollar (<a href=\"https://seekingalpha.com/symbol/UUP\" title=\"PowerShares DB USD Bull ETF\">UUP</a>, <a href=\"https://seekingalpha.com/symbol/UDN\" title=\"PowerShares DB USD Bear ETF\">UDN</a>) has popped from modestly lower on the session, to <font color=\"green\">up 0.3%</font>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200699\" data-linked=\"Futures and bond yields move higher after jobs numbers\" data-tweet=\"$SPY $QQQ $DIA - Futures and bond yields move higher after jobs numbers https://seekingalpha.com/news/3200699-futures-and-bond-yields-move-higher-after-jobs-numbers?source=tweet\" data-url=\"https://seekingalpha.com/news/3200699-futures-and-bond-yields-move-higher-after-jobs-numbers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:46 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>18&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200689\" data-ts=\"1470400427\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BMY\" target=\"_blank\">BMY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200689-bristol-myers-says-lung-cancer-drug-failed-to-meet-primary-endpoint\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bristol-Myers says lung cancer drug failed to meet primary endpoint</a></h4><ul>     <li>Bristol-Myers Squibb (NYSE:<a href=\"https://seekingalpha.com/symbol/BMY\" title=\"Bristol-Myers Squibb Company\">BMY</a>) <font color=\"red\">-16.7%</font> premarket after announcing that CheckMate -026, a Phase 3 trial investigating the use of Opdivo as a therapy, did not meet its primary endpoint of progression-free survival in certain patients with previously untreated advanced non-small cell lung cancer; shares resume after a trading halt.</li>     <li>Merck (NYSE:<a href=\"https://seekingalpha.com/symbol/MRK\" title=\"Merck &amp; Co Inc.\">MRK</a>) <font color=\"green\">+10.7%</font> premarket on potentially reduced competition for its Keytruda lung cancer drug; in June, MRK\u2019s similar trial investigating the use of Keytruda for the same condition met its primary endpoint.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200689\" data-linked=\"Bristol-Myers says lung cancer drug failed to meet primary endpoint\" data-tweet=\"$BMY $BMY $MRK - Bristol-Myers says lung cancer drug failed to meet primary endpoint https://seekingalpha.com/news/3200689-bristol-myers-says-lung-cancer-drug-failed-to-meet-primary-endpoint?source=tweet\" data-url=\"https://seekingalpha.com/news/3200689-bristol-myers-says-lung-cancer-drug-failed-to-meet-primary-endpoint\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:33 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>65&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200677\" data-ts=\"1470399496\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/EGLT\" target=\"_blank\">EGLT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200677-fda-panel-backs-approval-of-egalets-abuse-resistant-painkiller\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA panel backs approval of Egalet&#39;s abuse-resistant painkiller</a></h4><ul>     <li>Egalet (<a href=\"https://seekingalpha.com/symbol/EGLT\" title=\"Egalet Ltd.\">OTC:EGLT</a>) <font color=\"green\">+17.8%</font> AH following a positive vote from an FDA panel for the company's abuse-deterrent ARYMO ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment.</li>\n<li>Addicts frequently attempt to increase the speed with which opioids get  into their bloodstream by chewing or crushing the pills, or by  dissolving and injecting them; EGLT's tablets are designed to be extremely hard, making them <a href=\"http://www.reuters.com/article/us-egalet-arymo-fda-idUSKCN10F2H3\" target=\"_blank\">more difficult to break down</a> to extract the active ingredient.</li>     <li>The panel voted 18-1 to recommend approval of ARYMO ER; the FDA's final decision is scheduled for Oct. 14.</li>\n<li>EGLT also reported a larger than expected <a href=\"https://seekingalpha.com/news/3200556-egalet-misses-0_15-misses-revenue\" target=\"_blank\">Q2 loss</a>.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200677\" data-linked=\"FDA panel backs approval of Egalet&#39;s abuse-resistant painkiller\" data-tweet=\"$EGLT $ZCOR - FDA panel backs approval of Egalet&#39;s abuse-resistant painkiller https://seekingalpha.com/news/3200677-fda-panel-backs-approval-of-egalets-abuse-resistant-painkiller?source=tweet\" data-url=\"https://seekingalpha.com/news/3200677-fda-panel-backs-approval-of-egalets-abuse-resistant-painkiller\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:18 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200647\" data-ts=\"1470396765\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VER\" target=\"_blank\">VER</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200647-vereit-upsizes-capital-raise-down-1-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vereit upsizes capital raise, down 1% premarket</a></h4><ul>\n<li>The company sold 60M shares of common stock, up from the originally planned 50M. Expected gross proceeds of $621M suggests pricing of $10.35 each. The underwriters have an option to buy up to another 9M shares at that price.</li>\n<li>\n<a href=\"https://seekingalpha.com/symbol/VER\" title=\"VEREIT Inc.\">VER</a> <font color=\"red\">-1.14%</font> premarket to $10.37.</li>\n</ul><div class=\"tiny-share-widget\" data-id=\"3200647\" data-linked=\"Vereit upsizes capital raise, down 1% premarket\" data-tweet=\"$VER - Vereit upsizes capital raise, down 1% premarket https://seekingalpha.com/news/3200647-vereit-upsizes-capital-raise-down-1-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3200647-vereit-upsizes-capital-raise-down-1-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200642\" data-ts=\"1470396233\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/HMSY\" target=\"_blank\">HMSY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200642-on-hms-holdings-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on HMS Holdings&#39; Q2</a></h4><ul>     <li>HMS Holdings (NASDAQ:<a href=\"https://seekingalpha.com/symbol/HMSY\" title=\"HMS Holdings Corp\">HMSY</a>) reports Commercial health plan revenue rose 12% to $55.2M in Q2.</li>     <li>Payment integrity revenue (excl. Medicare RAC) fell 0.7% to $29.8M.</li>     <li>Coordination of benefits revenue grew 8.9% to $89.7M.</li>     <li>Non-Medicare RAC Federal and other revenue +3.1% to $6.7M.</li>     <li>Operating margin rate advanced 310 bps to 13.2%.</li>     <li>Adjusted EBITDA improved 13.4% to $32.32M.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200642\" data-linked=\"More on HMS Holdings&#39; Q2\" data-tweet=\"$HMSY - More on HMS Holdings&#39; Q2 https://seekingalpha.com/news/3200642-on-hms-holdings-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3200642-on-hms-holdings-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3200637\" data-ts=\"1470395361\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/CST\" target=\"_blank\">CST</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3200637-on-cst-brands-q2\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">More on CST Brands&#39; Q2</a></h4><ul>     <li>CST Brands (NYSE:<a href=\"https://seekingalpha.com/symbol/CST\" title=\"CST Brands\">CST</a>) reports U.S. retail merchandise and services revenue rose 21.2% to $474M in Q2.</li>     <li>Canadian retail merchandise and services revenue grew 4.5% to $70M.</li>     <li>U.S. merchandise and services gross margin rate improved 110 bps to 33.8%.</li>     <li>Company-operated retail store base increased 19% Y/Y through acquisitions and new-to-industry store construction.</li>     <li>U.S. retail store count +232 Y/Y to 1,225.</li>     <li>\n<b>Q3 Guidance</b>: U.S. retail merchandise and services gross margin: 33.5% to 34.5%; U.S. retail merchandise and services sales per store per day: $4,400 to $4,500; Canadian retail merchandise and services gross margin: 30.5% to 31.5%; Canadian retail merchandise and services sales per store per day: $2,550 to $2,650.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3200637\" data-linked=\"More on CST Brands&#39; Q2\" data-tweet=\"$CST - More on CST Brands&#39; Q2 https://seekingalpha.com/news/3200637-on-cst-brands-q2?source=tweet\" data-url=\"https://seekingalpha.com/news/3200637-on-cst-brands-q2\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:09 AM </div></div></li>","count":46,"message":null,"success":true,"today":{"start":1576990800,"end":1577077199,"str":"Sunday, December 22, 2019"},"yesterday":{"start":1576904400,"end":1576990799}}